✦ LIBER ✦

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary

✍ Scribed by György Jermendy; the Hungarian RECAP Group; Diana Erdesz; Laszlo Nagy; Don Yin; Hemant Phatak; Sudeep Karve; Samuel Engel; Rajesh Balkrishnan

Book ID: 119902923
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 522 KB
Volume: 6
Category: Article
ISSN: 1477-7525
DOI: 10.1186/1477-7525-6-88

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB25 COSTS AND EFFECTIVENESS OF INSULIN

PDB25 COSTS AND EFFECTIVENESS OF INSULIN VS. ROSIGLITAZONE IN TYPE 2 DIABETES AFTER METFORMIN MONOTHERAPY FAILURE

✍ J Skoupá; V Cerna; V Rausova; P Pavlikova 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

What Next after Metformin? A Retrospecti

What Next after Metformin? A Retrospective Evaluation of the Outcome of Second-Line, Glucose-Lowering Therapies in People with Type 2 Diabetes

✍ Morgan, Christopher Ll.; Poole, Chris D.; Evans, Marc; Barnett, Anthony H.; Jenk 📂 Article 📅 2012 🏛 Endocrine Society 🌐 English ⚖ 239 KB

A retrospective cohort study of economic

A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the united states from 2003 to 2005

✍ Richard A. Hansen; Joel F. Farley; Marcus Droege; Matthew L. Maciejewski 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 136 KB